XML 46 R35.htm IDEA: XBRL DOCUMENT v3.7.0.1
Stockholders' Equity (Tables)
3 Months Ended
Mar. 31, 2017
Stockholders' Equity  
Summary of changes in stockholders' equity

 

 

 

 

 

 

 

Three Months

 

 

 

Ended

 

 

 

March 31, 

 

 

    

2017

 

 

 

(in thousands)

 

 

 

 

 

 

Stockholders’ equity as of December 31, 2016

 

$

329,255

 

Beginning balance adjustment to retained earnings as a result of the adoption of ASU 2016-09

 

 

872

 

Adjusted stockholders' equity as of January 1, 2017

 

 

330,127

 

Net income

 

 

893

 

Accumulated other comprehensive income

 

 

466

 

Issuance of common stock in connection with the Company's equity plans

 

 

(2,173)

 

Share-based compensation expense

 

 

4,451

 

Treasury stock acquired

 

 

(8,203)

 

Stockholders’ equity as of March 31, 2017

 

$

325,561

 

 

Schedule of key assumptions to determine fair value of options

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

 

 

 

March 31, 

 

 

 

    

2017

    

2016

    

 

Average volatility

 

36.7

%  

30.2

%  

 

Risk-free interest rate

 

2.2

%  

1.6

%  

 

Weighted-average expected life in years

 

5.7

 

5.7

 

 

Dividend yield rate

 

 —

%  

 —

%  

 

 

Schedule of the summary of option activity under all plans

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-Average

 

 

 

 

 

 

 

 

Weighted-Average

 

Remaining

 

Aggregate

 

 

 

 

 

Exercise

 

Contractual

 

Intrinsic

 

 

 

Options

 

Price

 

Term (Years)

 

Value(1)

 

 

 

 

 

 

 

 

 

 

(in thousands)

 

Outstanding as of December 31, 2016

    

12,530,297

    

$

14.57

    

    

    

 

    

 

Options granted

 

1,621,222

 

 

13.93

 

 

 

 

 

 

Options exercised

 

(8,063)

 

 

11.87

 

 

 

 

 

 

Options cancelled

 

(9,880)

 

 

12.97

 

 

 

 

 

 

Options expired

 

(6,250)

 

 

25.36

 

 

 

 

 

 

Outstanding as of March 31, 2017

 

14,127,326

 

$

14.50

 

4.64

 

$

20,642

 

Exercisable as of March 31, 2017

 

9,409,292

 

$

14.99

 

3.09

 

$

14,611

 


The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the estimated fair value of the Company’s common stock for those awards that have an exercise price below the estimated fair value at March 31, 2017.

Schedule of information relating to options grants

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

 

 

March 31, 

 

 

    

2017

    

2016

 

 

 

(in thousands, except per share data)

 

Weighted-average grant date fair value

 

$

4.87

 

$

3.37

 

Intrinsic value of options exercised

 

 

24

 

 

15

 

Cash received

 

 

96

 

 

104

 

Total fair value of the options vested during the year

 

 

4,781

 

 

3,259

 

 

Schedule of the summary of nonvested options status

 

 

 

 

 

 

 

 

    

 

    

Weighted-Average

 

 

 

 

 

Grant Date

 

 

 

Options

 

Fair Value

 

Nonvested as of December 31, 2016

 

4,592,187

 

$

3.61

 

Options granted

 

1,621,222

 

 

4.87

 

Options vested

 

(1,485,495)

 

 

3.22

 

Options forfeited

 

(9,880)

 

 

4.51

 

Nonvested as of March 31, 2017

 

4,718,034

 

 

4.16

 

 

Schedule of information relating to RSU grants and deliveries

 

 

 

 

 

 

 

 

 

 

 

 

Total Fair Market

 

 

 

 

 

Value of RSUs

 

 

 

 

 

Issued

 

 

 

Total RSUs

 

as

 

 

    

Issued

    

Compensation(1)

 

 

 

 

 

(in thousands)

 

RSUs outstanding at December 31, 2016

 

1,215,786

 

 

 

 

RSUs granted

 

589,165

 

$

7,865

 

RSUs forfeited

 

(2,154)

 

 

 

 

Common stock delivered

 

(234,328)

 

 

 

 

RSUs surrendered for taxes

 

(163,510)

 

 

 

 

RSUs outstanding at March 31, 2017

 

1,404,959

 

 

 

 


The total fair market value is derived from the number of RSUs granted times the current stock price on the date of grant.

Schedule of recorded share-based compensation expense under all plans

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

 

 

March 31, 

 

 

 

2017

 

2016

 

 

 

(in thousands)

 

Cost of revenues

    

$

1,131

    

$

799

 

Operating expenses:

 

 

 

 

 

 

 

Selling, distribution, and marketing

 

 

84

 

 

66

 

General and administrative

 

 

2,783

 

 

2,646

 

Research and development

 

 

453

 

 

340

 

Total share-based compensation

 

$

4,451

 

$

3,851